Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Cabot Buying Norit for $1.1B

By Pharmaceutical Processing | June 21, 2012

BOSTON (AP) — Chemical and specialty products maker Cabot Corp. is buying Norit NV for $1.1 billion in order to strengthen its specialty chemicals portfolio.

Norit, which is based in the Netherlands, specializes in activated carbon products, which are used in environmental protection, air and water purification, food and beverages, pharmaceuticals and catalysts. It has 10 manufacturing plants located throughout Europe and the Americas and 760 employees.

Boston-based Cabot is buying Norit from affiliates of Doughty Hanson & Co. Managers Ltd. and Euroland Investments BV.

“This acquisition supports the ongoing transformation of our portfolio to a higher margin, less cyclical, specialty chemicals focused company,” Cabot President and CEO Patrick Prevost said in a statement.

Norit will continue to be led by CEO Ronald Thompson.

The acquisition is expected to add 20 cents to 25 cents per share to fiscal 2013 earnings and 30 cents to 40 cents per share in fiscal 2014. The estimates exclude one-time costs.

The deal is expected to close this year. It requires the approval of U.S. and German regulators and consultation with the Dutch labor council.

Cabot said Thursday that it expects to fund the deal with about $200 million in cash and $300 million of borrowings under a credit agreement. It also plans to issue about $600 million of long-term debt.

Cabot shares closed at $37.97 on Wednesday. They have traded in a 52-week range of $22.45 to $44.97.

 

 

Related Articles Read More >

Schott Pharma $60M vial production investment (1)
Schott Pharma invests $60M to expand vial production in Pennsylvania
Niowave Logo
Niowave breaks ground on $75M isotope production facility
Fujifilm Cellular Dynamics Madison Wisconsin opening
Fujifilm Cellular Dynamics opens new stem cell manufacturing plant in Wisconsin
This is the logo of Eli Lilly.
Eli Lilly commits $4.5B to Indiana manufacturing sites, opens gene therapy plant
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE